LifeSpan Vision Ventures, an investment firm dedicated to longevity biotech, announced an investment in NaNotics LLC. This preclinical-stage biopharmaceutical company is developing NaNots™, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from the blood.